Adell A (2020) Brain NMDA receptors in schizophrenia and depression. Biomolecules 10(6):947. Available from: https://doi.org/10.3390/biom10060947

Bakshi VP, Geyer MA (1998) Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine. J Neurosci 18(20):8394–401

Article  CAS  PubMed  PubMed Central  Google Scholar 

Benes FM (2011) Regulation of cell cycle and DNA repair in post-mitotic GABA neurons in psychotic disorders. Neuropharmacology 60(7–8):1232–42

Article  CAS  PubMed  Google Scholar 

Ben-Zion IZ, Meiri G, Greenberg BD, Murphy DL, Benjamin J (1999) Enhancement of CO2-induced anxiety in healthy volunteers with the serotonin antagonist metergoline. Am J Psychiatry 156(10):1635–7

Article  CAS  PubMed  Google Scholar 

Berk M, Nierenberg AA (2015) Three paths to drug discovery in psychiatry. Am J Psychiatry 172(5):412–4

Article  PubMed  Google Scholar 

Braff DL (1993) Information processing and attention dysfunctions in schizophrenia. Schizophr Bull 19(2):233–59

Article  CAS  PubMed  Google Scholar 

Cheetham SC, Heal DJ (1993) Evidence that RU 24969-induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5-HT1B receptor. Br J Pharmacol 110(4):1621–9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chu TT, Liu Y, Kemether E (2009) Thalamic transcriptome screening in three psychiatric states. J Hum Genet 54(11):665–75

Article  CAS  PubMed  Google Scholar 

Cummings J, Isaacson S, Mills R, Williams H, Chi-Burris K, Corbett A et al (2014) Pimavanserin for patients with Parkinson’s disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet 383(9916):533–40

Article  CAS  PubMed  Google Scholar 

Dallérac G, Li X, Lecouflet P, Morisot N, Sacchi S, Asselot R, ... Mothet JP (2021) Dopaminergic neuromodulation of prefrontal cortex activity requires the NMDA receptor coagonist d-serine. Proc Natl Acad Sci USA 118(23). Available from: https://doi.org/10.1073/pnas.2023750118

Frydecka D, Krzystek-Korpacka M, Lubeiro A, Stramecki F, Stańczykiewicz B, Beszłej JA et al (2018) Profiling inflammatory signatures of schizophrenia: a cross-sectional and meta-analysis study. Brain Behav Immun 71:28–36

Article  PubMed  Google Scholar 

Ghanizadeh A, Rezaee Z, Dehbozorgi S, Berk M, Akhondzadeh S (2014) Lovastatin for the adjunctive treatment of schizophrenia: a preliminary randomized double-blind placebo-controlled trial. Psychiatry Res 219(3):431–5

Article  CAS  PubMed  Google Scholar 

Glass JD, Brager AJ, Stowie AC, Prosser RA (2012) Cocaine modulates pathways for photic and nonphotic entrainment of the mammalian SCN circadian clock. Am J Physiol Regul Integr Comp Physiol 302(6):R740-50

Article  CAS  PubMed  Google Scholar 

Gobira PH, Ropke J, Aguiar DC, Crippa JA, Moreira FA (2013) Animal models for predicting the efficacy and side effects of antipsychotic drugs. Braz J Psychiatry 35(Suppl 2):S132-9

Article  PubMed  Google Scholar 

Gogos A, Bogeski M, van den Buuse M (2008) Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology. Behav Pharmacol 19(5–6):548–61

Article  CAS  PubMed  Google Scholar 

Gogos A, Kusljic S, van den Buuse M (2005) 8-OH-DPAT-induced effects on prepulse inhibition: pre- vs. post-synaptic 5-HT1A receptor activation. Pharmacol Biochem Behav 81(3):664–72

Guillin O, Abi-Dargham A, Laruelle M (2007) Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol 78:1–39

Article  CAS  PubMed  Google Scholar 

Haaf M, Leicht G, Curic S, Mulert C (2018) Glutamatergic deficits in schizophrenia - biomarkers and pharmacological interventions within the ketamine model. Curr Pharm Biotechnol 19(4):293–307

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hawi Z, Tong J, Dark C, Yates H, Johnson B, Bellgrove MA (2018) The role of cadherin genes in five major psychiatric disorders: a literature update [Internet]. Vol. 177, Am J Med Genet B Neuropsychiatr Genet 168–80. Available from: https://doi.org/10.1002/ajmg.b.32592

Hendouei N, Saghafi F, Shadfar F, Hosseinimehr SJ (2019) Molecular mechanisms of anti-psychotic drugs for improvement of cancer treatment. Eur J Pharmacol 5(856):172402

Article  Google Scholar 

Howes O, McCutcheon R, Stone J (2015) Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol 29(2):97–115

Article  PubMed  PubMed Central  Google Scholar 

Jóźwiak-Bębenista M, Jasińska-Stroschein M, Kowalczyk E (2018) Involvement of vascular endothelial growth factor (VEGF) and mitogen-activated protein kinases (MAPK) in the mechanism of neuroleptic drugs. Pharmacol Rep 70(5):1032–9

Article  PubMed  Google Scholar 

Jones CA, Watson DJG, Fone KCF (2011) Animal models of schizophrenia. Br J Pharmacol 164:1162–1194

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kantrowitz JT, Javitt DC (2010) N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res Bull 83(3–4):108–21

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kidnapillai S, Bortolasci CC, Udawela M, Panizzutti B, Spolding B, Connor T et al (2020) The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder. World J Biol Psychiatry 21(10):775–83

Article  PubMed  Google Scholar 

Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL (2013) TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 14(4):R36

Article  PubMed  PubMed Central  Google Scholar 

Kirlioglu SS, Balcioglu YH (2020) Chronobiology revisited in psychiatric disorders: from a translational perspective. Psychiatry Investig 17(8):725–43

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kosik KS, Donahue CP, Israely I, Liu X, Ochiishi T (2005) Delta-catenin at the synaptic-adherens junction. Trends Cell Biol 15(3):172–8

Article  CAS  PubMed  Google Scholar 

Kraeuter AK, Mashavave T, Suvarna A, van den Buuse M, Sarnyai Z (2020) Effects of beta-hydroxybutyrate administration on MK-801-induced schizophrenia-like behaviour in mice. Psychopharmacology 237(5):1397–405

Article  CAS  PubMed  Google Scholar 

Kulkarni J, Gavrilidis E, Gwini SM, Worsley R, Grigg J, Warren A et al (2016) Effect of adjunctive raloxifene therapy on severity of refractory schizophrenia in women [Internet]. Vol. 73., JAMA Psychiatry 947. Available from: https://doi.org/10.1001/jamapsychiatry.2016.1383

Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ et al (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313(5795):1929–35

Article  CAS  PubMed  Google Scholar 

Laruelle M, Frankle WG, Narendran R, Kegeles LS, Abi-Dargham A (2005) Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation. Clin Ther 27 Suppl A:S16–24

Maes M, Sirivichayakul S, Kanchanatawan B, Vodjani A (2019) Upregulation of the intestinal paracellular pathway with breakdown of tight and adherens junctions in deficit schizophrenia. Mol Neurobiol 56(10):7056–73

Article  CAS  PubMed  Google Scholar 

Maes M, Vojdani A, Sirivichayakul S, Barbosa D, Kanchanatawan B (2021) Inflammatory and oxidative pathways are new drug targets in multiple episode schizophrenia and leaky gut, Klebsiella pneumoniae, and C1q immune complexes are additional drug targets in first episode schizophrenia [Internet]. Available from: https://doi.org/10.20944/preprints202012.0457.v1

Manning EE, van den Buuse M (2013) BDNF deficiency and young-adult methamphetamine induce sex-specific effects on prepulse inhibition regulation. Front Cell Neurosci 12(7):92

Google Scholar 

Mohr D, Pilz PKD, Plappert CF, Fendt M (2007) Accumbal dopamine D2 receptors are important for sensorimotor gating in C3H mice. Neuroreport 18(14):1493–7

Article  CAS  PubMed  Google Scholar 

Moon E, Lavin P, Storch KF, Linnaranta O (2021) Effects of antipsychotics on circadian rhythms in humans: a systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 8(108):110162

Article  Google Scholar 

Nanry KP, Tilson HA (1989) The role of 5HT1A receptors in the modulation of the acoustic startle reflex in rats. Psychopharmacology 97(4):507–13

Article  CAS  PubMed  Google Scholar 

Nikiforuk A (2018) Assessment of cognitive functions in animal models of schizophrenia. Pharmacol Rep 70(4):639–649

Article  PubMed  Google Scholar 

Notaras MJ, Hill RA, Gogos JA, van den Buuse M (2017) BDNF Val66Met genotype interacts with a history of simulated stress exposure to regulate sensorimotor gating and startle reactivity. Schizophr Bull 43(3):665–72

PubMed  Google Scholar 

Pellow S, Johnston AL, File SE (1987) Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat. J Pharm Pharmacol 39(11):917–28

Article  CAS  PubMed  Google Scholar 

Pjrek E, Winkler D, Kasper S (2005) Pharmacotherapy of seasonal affective disorder [Internet]. Vol. 10, CNS Spectrums 664–9. Available from: https://doi.org/10.1017/s1092852900019623

Pleasure SJ, Page C, Lee VM (1992) Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci 12(5):1802–15

Article  CAS  PubMed  PubMed Central  Google Scholar